$2.41T
Total marketcap
$73.95B
Total volume
BTC 50.90%     ETH 14.95%
Dominance

Paragon 28, Inc. 7GQ.F Stock

9.65 EUR {{ price }} 1.047114% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
800.04M EUR
LOW - HIGH [24H]
9.65 - 9.65 EUR
VOLUME [24H]
25 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.54 EUR

Paragon 28, Inc. Price Chart

Paragon 28, Inc. 7GQ.F Financial and Trading Overview

Paragon 28, Inc. stock price 9.65 EUR
Previous Close 16.8 EUR
Open 16.6 EUR
Bid 16.6 EUR x N/A
Ask 17.1 EUR x N/A
Day's Range 16.6 - 16.6 EUR
52 Week Range 14.5 - 20 EUR
Volume 10 EUR
Avg. Volume 0 EUR
Market Cap 1.4B EUR
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.54 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

7GQ.F Valuation Measures

Enterprise Value 1.33B EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 7.274446
Price/Book (mrq) 6.658644
Enterprise Value/Revenue 6.934
Enterprise Value/EBITDA -67.345

Trading Information

Paragon 28, Inc. Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 10.59%
S&P500 52-Week Change 20.43%
52 Week High 20 EUR
52 Week Low 14.5 EUR
50-Day Moving Average 16.1 EUR
200-Day Moving Average 17.28 EUR

7GQ.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 82.32M
Float 34.18M
Short Ratio N/A
% Held by Insiders 42.15%
% Held by Institutions 38.27%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -34.96%
Operating Margin (ttm) -17.48%
Gross Margin 81.99%
EBITDA Margin -10.29%

Management Effectiveness

Return on Assets (ttm) -7.21%
Return on Equity (ttm) -34.46%

Income Statement

Revenue (ttm) 192.05M EUR
Revenue Per Share (ttm) 2.47 EUR
Quarterly Revenue Growth (yoy) 25.80%
Gross Profit (ttm) 148.93M EUR
EBITDA -19775000 EUR
Net Income Avi to Common (ttm) -67142000 EUR
Diluted EPS (ttm) -0.8
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 85.88M EUR
Total Cash Per Share (mrq) 1.04 EUR
Total Debt (mrq) 42.89M EUR
Total Debt/Equity (mrq) 20.91 EUR
Current Ratio (mrq) 3.096
Book Value Per Share (mrq) 2.493

Cash Flow Statement

Operating Cash Flow (ttm) -53738000 EUR
Levered Free Cash Flow (ttm) -35935000 EUR

Profile of Paragon 28, Inc.

Country Germany
State CO
City Englewood
Address 14445 Grasslands Drive
ZIP 80112
Phone 720 912 1332
Website https://www.paragon28.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 463

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Q&A For Paragon 28, Inc. Stock

What is a current 7GQ.F stock price?

Paragon 28, Inc. 7GQ.F stock price today per share is 9.65 EUR.

How to purchase Paragon 28, Inc. stock?

You can buy 7GQ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Paragon 28, Inc.?

The stock symbol or ticker of Paragon 28, Inc. is 7GQ.F.

Which industry does the Paragon 28, Inc. company belong to?

The Paragon 28, Inc. industry is Medical Devices.

How many shares does Paragon 28, Inc. have in circulation?

The max supply of Paragon 28, Inc. shares is 82.91M.

What is Paragon 28, Inc. Price to Earnings Ratio (PE Ratio)?

Paragon 28, Inc. PE Ratio is now.

What was Paragon 28, Inc. earnings per share over the trailing 12 months (TTM)?

Paragon 28, Inc. EPS is -0.54 EUR over the trailing 12 months.

Which sector does the Paragon 28, Inc. company belong to?

The Paragon 28, Inc. sector is Healthcare.